How the U.S. generic drug supply chain works

Generic Drugs Forum (GDF) 2024: Regulatory Considerations to Enhance Generic Drug Access-Day 1, Pt 1Подробнее

Assessing Generic & Biosimilar Manufacturing in North AmericaПодробнее

Pharmaceutical Supply Chains And Drug ShortagesПодробнее

Expanding Generic Drug Access Through International EngagementsПодробнее

[English] Building a High Quality US-Mexico Pharmaceutical Supply ChainПодробнее

ReVAMPing the Pharmaceutical Supply Chain: Implementing Policy to Prevent Drug ShortagesПодробнее

Media Partnership - The Essential Role of Generic Medicines in Ensuring Supply Security in EuropeПодробнее

Generic Drugs Forum (GDF) 2024: Regulatory Considerations to Enhance Generic Drug Access - Day 1Подробнее

Panel Discussion - Working Towards Ensuring Adequate Drug Supply | 8th Advanced GMP Workshop 2023Подробнее

Legislative Proposals to Prevent and Respond to Generic Drug ShortagesПодробнее

Drug Shortages and the Pharmaceutical Supply Chain | Conversation with Dr. Erin FoxПодробнее

40% of generic drugs are made by one manufacturerПодробнее

O&I: Examining the Root Causes of Drug Shortages: Challenges in Pharmaceutical Drug Supply ChainsПодробнее

Health Hearing: "Legislative Proposals to Prevent and Respond to Generic Drug Shortages"Подробнее

US Drug Supply Chain: The BasicsПодробнее

Building a Resilient Drug Supply Chain Duke-Margolis Center WebinarПодробнее

How Mark Cuban Is Trying to Disrupt Big Pharma | WSJПодробнее

Examining the Root Causes of Drug Shortages: Challenges in Pharmaceutical Drug Supply ChainsПодробнее

How the prescription drug supply chain is killing local pharmaciesПодробнее